Skip to main content
47°
Partly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
C4 Therapeutics, Inc. - Common Stock
(NQ:
CCCC
)
6.900
UNCHANGED
Streaming Delayed Price
Updated: 4:15 PM EDT, Apr 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
7
Open
6.900
Bid (Size)
6.980 (4)
Ask (Size)
7.060 (1)
Prev. Close
6.900
Today's Range
6.900 - 6.900
52wk Range
1.060 - 11.88
Shares Outstanding
48,797,226
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
C4 Therapeutics to Participate in the Stifel 2024 Targeted Oncology Forum
April 09, 2024
From
C4 Therapeutics, Inc.
Via
GlobeNewswire
C4 Therapeutics Presents New Preclinical Data for CFT1946 Highlighting Superior Activity as a Single Agent to Clinically Approved BRAF Inhibitor Standard of Care Combinations at the American Association for Cancer Research Annual Meeting 2024
April 08, 2024
From
C4 Therapeutics, Inc.
Via
GlobeNewswire
Performance
YTD
+5.83%
+5.83%
1 Month
-15.96%
-15.96%
3 Month
+22.34%
+22.34%
6 Month
+389.36%
+389.36%
1 Year
+119.05%
+119.05%
More News
Read More
C4 Therapeutics to Present New Preclinical Data on Highly Selective Orally Bioavailable BiDAC™ Degraders at the American Association for Cancer Research Annual Meeting 2024
March 05, 2024
From
C4 Therapeutics, Inc.
Via
GlobeNewswire
Breaking Down C4 Therapeutics: 4 Analysts Share Their Views
February 26, 2024
Via
Benzinga
Analyst Expectations For C4 Therapeutics's Future
January 29, 2024
Via
Benzinga
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Germany, Against Critical Oncogenic Proteins
March 04, 2024
From
C4 Therapeutics, Inc.
Via
GlobeNewswire
C4 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
February 22, 2024
From
C4 Therapeutics, Inc.
Via
GlobeNewswire
Capital One Financial To Acquire Discover, Joins SSR Mining And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
February 20, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
7 Exciting Stocks Poised for Explosive Growth in Key Sectors
January 22, 2024
Via
InvestorPlace
C4 Therapeutics Inc. (NASDAQ: CCCC) Leading the Way in Wednesday Trading Based on Percentage Gain
January 10, 2024
Via
Investor Brand Network
C4 Therapeutics Announces 2024 Priorities and Extended Cash Runway to Advance Portfolio of Targeted Protein Degradation Medicines
January 09, 2024
From
C4 Therapeutics, Inc.
Via
GlobeNewswire
C4 Therapeutics Announces Closing of $25 Million Equity Investment by Betta Pharmaceuticals
January 04, 2024
From
C4 Therapeutics, Inc.
Via
GlobeNewswire
C4 Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 04, 2024
From
C4 Therapeutics, Inc.
Via
GlobeNewswire
MarketBeat Week in Review – 12/18 - 12/22
December 23, 2023
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
C4 Therapeutics blasts off: what's next?
December 18, 2023
Via
MarketBeat
Topics
ETFs
C4 Therapeutics Inc. (NASDAQ: CCCC) Near Top of Volume Charts in Friday Trading
December 15, 2023
Via
Investor Brand Network
What's Going On With C4 Therapeutics Stock?
December 15, 2023
Via
Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
December 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 15, 2023
Via
Benzinga
C4 Therapeutics Inc. (NASDAQ: CCCC) is One of Thursday Morning’s Most Active Stocks
December 14, 2023
Via
Investor Brand Network
Dow Jumps Over 200 Points; Federal Reserve Holds Interest Rates Steady
December 13, 2023
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
December 13, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 13, 2023
Via
Benzinga
Crude Oil Gains 1.5%; Blackboxstocks Shares Plummet
December 13, 2023
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
C4 Therapeutics Inc. (NASDAQ: CCCC) is One of Wednesday Morning’s Most Active Stocks
December 13, 2023
Via
Investor Brand Network
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.